Dexmedetomidine
An overview of the sedative medication Dexmedetomidine
Dexmedetomidine[edit]

Dexmedetomidine is a medication primarily used for its sedative and analgesic properties. It is a selective alpha-2 adrenergic receptor agonist, which means it works by stimulating alpha-2 receptors in the brain, leading to sedation and pain relief. Dexmedetomidine is commonly used in ICU settings and during anesthesia for surgical procedures.
Pharmacology[edit]
Dexmedetomidine acts on the central nervous system by binding to alpha-2 adrenergic receptors. This action decreases the release of norepinephrine, resulting in sedation, anxiolysis, and analgesia. Unlike other sedatives, dexmedetomidine does not cause significant respiratory depression, making it a preferred choice in certain clinical situations.
Clinical Uses[edit]
Dexmedetomidine is used in various clinical settings, including:
- Sedation in ICU: It is used for sedation of mechanically ventilated patients in the ICU.
- Procedural sedation: It is used for sedation during procedures that do not require general anesthesia.
- Adjunct to anesthesia: It is used as an adjunct to general anesthesia to provide sedation and analgesia.
Side Effects[edit]
Common side effects of dexmedetomidine include:
- Hypotension
- Bradycardia
- Dry mouth
- Nausea
Administration[edit]
Dexmedetomidine is typically administered intravenously. The dosage and rate of administration depend on the clinical context and the desired level of sedation.
Mechanism of Action[edit]

Dexmedetomidine's mechanism of action involves the activation of presynaptic alpha-2 adrenergic receptors, which inhibits the release of norepinephrine. This leads to a decrease in sympathetic nervous system activity, resulting in sedation and analgesia.
Advantages[edit]
One of the main advantages of dexmedetomidine is its ability to provide sedation without causing significant respiratory depression. This makes it particularly useful in patients who are at risk of respiratory complications.
Related pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian